Pre-Tax Income: Company's earnings or loss before taxes on income have been accounted for.
PDS Biotechnology Corporation (PDSB) had Pre-Tax Income of $-9.75M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-9.75M |
|
-- |
|
-- |
|
$6.50M |
|
$-6.50M |
|
$-3.25M |
|
|
Pre-Tax Income |
$-9.75M |
$-9.75M |
|
$-9.75M |
|
$-9.75M |
|
$-9.75M |
|
$-9.75M |
|
$-6.50M |
|
$-6.22M |
|
55.66M |
|
55.66M |
|
$-0.18 |
|
$-0.18 |
|
| Balance Sheet Financials | |
$7.05M |
|
$0.18M |
|
$1.76M |
|
$8.81M |
|
$12.38M |
|
$0.01M |
|
$0.01M |
|
$12.39M |
|
$-3.58M |
|
$-3.58M |
|
$-3.58M |
|
55.92M |
|
| Cash Flow Statement Financials | |
$-7.16M |
|
-- |
|
$-13.95M |
|
$26.71M |
|
$5.60M |
|
$-21.12M |
|
$2.28M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.57 |
|
-- |
|
-- |
|
-0.00 |
|
-1.22 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-7.16M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
272.38% |
|
272.38% |
|
-110.71% |
|
273.11% |
|
$-0.06 |
|
$-0.13 |
|
$-0.13 |
|